ImmuneAGE

HexemBio

This company develops stem cell rejuvenation therapies using synthetic environments to treat blood cancer and age-related immune decline in human patients.

Neotis

This company develops immunotherapies targeting senescent cells to treat age-related and fibrotic diseases for patients with chronic conditions.

Thymmune

This biotechnology company develops scalable thymic cell therapies to restore immune function for patients with immunodeficiencies, autoimmune disorders, and transplant-related conditions.

BioAge Labs

This company develops therapeutic drugs targeting the biology of human aging to treat patients with metabolic and cardiovascular diseases.

Immunis

This biotechnology company develops stem cell-derived secretome therapies to treat age-related immune dysfunction and muscle wasting for patients with sarcopenia and metabolic diseases.

CellRep

CellRep develops an artificial intelligence platform discovering small molecules that rejuvenate immune cells for developers of cell therapies and regenerative medicine.

immunoforge

This biopharmaceutical company develops therapies for muscular and rare diseases by leveraging a long-acting platform technology to extend the half-life of peptide-based drugs.

Deciduous

This company develops medicines that activate the immune system to remove senescent cells for patients with age-related metabolic and fibrotic diseases.